Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: Evaluation of the therapeutic potential of novel nanoparticle formulations of glutathione and virgin coconut oil in an experimental model of carbon tetrachloride-induced liver failure

Fig. 1

The impact of different forms of glutathione (GSH) and virgin coconut oil (VCO), including conventional, nanoparticle, and combination forms, on blood levels of aspartate aminotransferase (AST), alanine transaminase (ALT), albumin (ALB), and alkaline phosphatase in rats with acute liver failure induced by carbon tetrachloride (CCl4). Data are the means ± SEM (n = 6). bp < 0.001 and ap < 0.0001 as compared with the control group. **p < 0.01 and ****p < 0.0001 as compared to the CCl4-treated group. #p < 0.05, ##p < 0.01, ###p < 0.001 and ####p < 0.0001 when contrasted with the related nanoparticle category. Note FO ferric oxide, CS chitosan, Nano-VCO virgin coconut oil nanoparticles, Nano-GSH glutathione nanoparticles, O virgin coconut oil-glutathione combinations, Nano-O virgin coconut oil-glutathione nanoparticle combinations

Back to article page